AAAAAA

   
Results: 1-9 |
Results: 9
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay
Authors: Becker, C Pohla, H Frankenberger, B Schuler, T Assenmacher, M Schendel, DJ Blankenstein, T
Citation: C. Becker et al., Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay, NAT MED, 7(10), 2001, pp. 1159-1162
Calcium signaling through the beta(2)-cytoplasmic domain of LFA-1 requiresintracellular elements of the T cell receptor complex
Authors: Sirim, P Zeitlmann, L Kellersch, B Falk, CS Schendel, DJ Kolanus, W
Citation: P. Sirim et al., Calcium signaling through the beta(2)-cytoplasmic domain of LFA-1 requiresintracellular elements of the T cell receptor complex, J BIOL CHEM, 276(46), 2001, pp. 42945-42956
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatmentof patients with Epstein-Barr virus-positive Hodgkin disease
Authors: Su, Z Peluso, MV Raffegerst, SH Schendel, DJ Roskrow, MA
Citation: Z. Su et al., The generation of LMP2a-specific cytotoxic T lymphocytes for the treatmentof patients with Epstein-Barr virus-positive Hodgkin disease, EUR J IMMUN, 31(3), 2001, pp. 947-958
HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex
Authors: Huck, C Endl, J Walk, T Noessner, E Jung, G Wank, R Schendel, DJ
Citation: C. Huck et al., HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex, DIABETOLOG, 44(1), 2001, pp. 70-80
Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse
Authors: Schendel, DJ Frankenberger, B Jantzer, P Cayeux, S Nossner, E Willimsky, G Maget, B Pohla, H Blankenstein, T
Citation: Dj. Schendel et al., Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse, GENE THER, 7(23), 2000, pp. 2007-2014
Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognitionbut suppresses non-MHC-restricted effector cell activity
Authors: Schendel, DJ Falk, CS Nossner, E Maget, B Kressenstein, S Urlinger, S Tampe, R Gansbacher, B
Citation: Dj. Schendel et al., Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognitionbut suppresses non-MHC-restricted effector cell activity, GENE THER, 7(11), 2000, pp. 950-959
Allogeneic vaccination for renal cell carcinoma: development and monitoring
Authors: Pohla, H Frankenberger, B Stadlbauer, B Oberneder, R Hofstetter, A Willimsky, G Pezzutto, A Dorken, B Blankenstein, T Schendel, DJ
Citation: H. Pohla et al., Allogeneic vaccination for renal cell carcinoma: development and monitoring, BONE MAR TR, 25, 2000, pp. S83-S87
Non-MHC-restricted CD4(+) T lymphocytes are regulated by HLA-Cw7-mediated inhibition
Authors: Falk, CS Nossner, E Frankenberger, B Schendel, DJ
Citation: Cs. Falk et al., Non-MHC-restricted CD4(+) T lymphocytes are regulated by HLA-Cw7-mediated inhibition, HUMAN IMMUN, 61(12), 2000, pp. 1219-1232
A PCR-SSP method to specifically select HLA-A0201 individuals for immunotherapeutic studies
Authors: Gatz, SA Pohla, H Schendel, DJ
Citation: Sa. Gatz et al., A PCR-SSP method to specifically select HLA-A0201 individuals for immunotherapeutic studies, TISSUE ANTI, 55(6), 2000, pp. 532-547
Risultati: 1-9 |